Longitudinal Collection of Patient-Reported Outcomes and Activity Data during CAR-T Therapy: Feasibility, Acceptability, and Data Visualization.

Laura B Oswald Xiaoyin Li Rodrigo Carvajal Aasha I HooglandLisa M GudenkaufDoris K HansenMelissa AlsinaFrederick L LockeYvelise RodriguezNathaly Irizarry-ArroyoEdmondo J Robinson Heather S L Jim Brian D Gonzalez Kedar S Kirtane

Published in: Cancers (2022)

Longitudinal PRO and activity data collection was feasible and acceptable. Data collected on a larger scale may be used to specify risk prediction models to identify predictors of severe CAR-T-related toxicities and inform early interventions.

Keyphrases

electronic health record
patient reported outcomes
big data
stem cells
cross sectional
data analysis
machine learning
drug induced
artificial intelligence
cell therapy
smoking cessation
replacement therapy